Stephen T. Chen - 27 Jun 2022 Form 4 Insider Report for Ainos, Inc. (AIMD)

Reporting relationship: FORMER DIRECTOR & OFFICER
Issuer ticker: AIMD
Reported as of: 27 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2022, 19:21:22 UTC
Source filing: View source filing
Reporting owner signature: /s/ John Junyong Lee, POA for Stephen T. Chen

Key filing fact

Stephen T. Chen filed Form 4 for Ainos, Inc. (AIMD) on 27 Jun 2022.

Key facts

This page summarizes Stephen T. Chen's Form 4 filing for Ainos, Inc. (AIMD).
0 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 27 Jun 2022, 19:21.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AIMD holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,938,227
Date: 27 Jun 2022
Ownership: Direct

AIMD holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 594,915
Date: 27 Jun 2022
Ownership: STC International
Footnotes: F1

AIMD holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 39,473
Date: 27 Jun 2022
Ownership: ACTS Biosciences
Footnotes: F2

AIMD holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 740,243
Date: 27 Jun 2022
Ownership: Spouse
Footnotes: F3

AIMD holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,527,967
Date: 27 Jun 2022
Ownership: Trust
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AIMD holding Derivative

Convertible Promissory Note

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 27 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 670,741
Exercise price: $0.1700
Footnotes: F5

AIMD holding Derivative

Convertible Promissory Note

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 0
Date: 27 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,381,578
Exercise price: $0.1900
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Stephen T. Chen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

STC International, Inc. - Stephen Chen is Chairman, Board Member and Major Stockholder

Footnote F2

ACTS Biosciences, Inc. - Stephen Chen is Chairman and Major Stockholder

Footnote F3

Spouse - Virginia M. Chen IRA

Footnote F4

Trust - Stephen T Chen Virginia M Chen TTEES Stephen T Virginia M Chen Living Trust DTD 04/12/2018

Footnote F5

On Demand

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .